Onconetix, Inc. — Director's Dealing 2022

Aug 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-08-22

Reporting Person: Tarsh Simon (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-22	Stock Option	$3.48	A	4073	Acquired	2032-08-22	Common Stock (4073)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Mr. Tarsh on August 22, 2022. The Options vest and become exercisable in 9 monthly installments beginning on September 22, 2022.